Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Chia Tai Chengxin Pharmaceutical is a specialized pharmaceutical manufacturer based in Jiaxing, China, and operates as a subsidiary of Sino Biopharmaceutical. Established in 1994, the company focuses on the research, development, and production of chemical drugs across several key therapeutic areas, including cardiovascular health, anti-infectives, and gastroenterology. Its manufacturing facilities are GMP-certified and produce both active pharmaceutical ingredients (APIs) and finished dosage forms such as tablets and capsules. As a strategic production base for the Chia Tai (CP) Group, the company supplies high-quality generic medicines to the Chinese domestic market and various international regions. Its portfolio includes widely recognized products like amlodipine and a range of macrolide antibiotics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Chiatai Chengxin Pharmaceutical.